Dapagliflozin and renal function. Re: Diabetes and kidney disease: the role of sodium-glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes. Mende CW. Curr Med Res Opin 2017;33:541-551

Min T.; Wali L.; Williams D. M.; Plummer E.; Gurung A.; Stephens J. W.

首页> 外文期刊>Current medical research and opinion >Dapagliflozin and renal function. Re: Diabetes and kidney disease: the role of sodium-glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes. Mende CW. Curr Med Res Opin 2017;33:541-551

【24h】

Dapagliflozin and renal function. Re: Diabetes and kidney disease: the role of sodium-glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes. Mende CW. Curr Med Res Opin 2017;33:541-551

机译：Dapagliflozin和肾功能。 Re：糖尿病和肾脏疾病：钠葡萄糖Cotoransporter-2（SGLT-2）和SGLT-2抑制剂在改性疾病结果中的作用。 Mende CW。 Curr Med Res Opim 2017; 33：541-551

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Current medical research and opinion》 |2017年第9期|共2页
作者
Min T.; Wali L.; Williams D. M.; Plummer E.; Gurung A.; Stephens J. W.;
展开▼
作者单位

Swansea Univ Sch Med Diabet Res Grp Grove Bldg Swansea SA6 8NL W Glam Wales;

ABM Univ Hlth Board Dept Diabet &

Endocrinol Swansea W Glam Wales;

ABM Univ Hlth Board Dept Diabet &

Endocrinol Swansea W Glam Wales;

ABM Univ Hlth Board Dept Diabet &

Endocrinol Swansea W Glam Wales;

ABM Univ Hlth Board Dept Diabet &

Endocrinol Swansea W Glam Wales;

Swansea Univ Sch Med Diabet Res Grp Grove Bldg Swansea SA6 8NL W Glam Wales;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. Dapagliflozin and renal function. Re: Diabetes and kidney disease: the role of sodium-glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes. Mende CW. Curr Med Res Opin 2017;33:541-551 [J] . Min T., Wali L., Williams D. M., Current medical research and opinion . 2017,第9期

机译：Dapagliflozin和肾功能。 Re：糖尿病和肾脏疾病：钠葡萄糖Cotoransporter-2（SGLT-2）和SGLT-2抑制剂在改性疾病结果中的作用。 Mende CW。 Curr Med Res Opim 2017; 33：541-551
2. Diabetes and kidney disease: the role of sodium-glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes [J] . Mende Christian W. Current medical research and opinion . 2017,第3期

机译：糖尿病和肾脏疾病：钠葡萄糖COTRANSPORTER-2（SGLT-2）和SGLT-2抑制剂在改性疾病结果方面的作用
3. The role of sodium glucose cotransporter-2 (SGLT-2) inhibitors in heart failure and chronic kidney disease in type 2 diabetes [J] . Woo Vincent, Connelly Kim, Lin Peter, Current medical research and opinion . 2019,第7期

机译：葡萄糖COT转储-2（SGLT-2）抑制剂在2型糖尿病中心力衰竭和慢性肾病中的作用
4. New Diabetes Therapies and Diabetic Kidney Disease Progression: the Role of SGLT-2 Inhibitors [O] . Claire C. J. Dekkers, Ron T. Gansevoort, Hiddo J. L. Heerspink -1

机译：新的糖尿病治疗和糖尿病肾病进展：SGLT-2抑制剂的作用
5. Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors: Benefits in Diabetics With Cardiovascular Disease [O] . Saba Aftab, Rishwanth Vetrivel Suresh, Nazleen Sherali, 2020

机译：葡萄糖Cotroansporter-2（SGLT-2）抑制剂：糖尿病患者患有心血管疾病的益处

Dapagliflozin and renal function. Re: Diabetes and kidney disease: the role of sodium-glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes. Mende CW. Curr Med Res Opin 2017;33:541-551

著录项

相似文献

相关主题

期刊订阅